154 related articles for article (PubMed ID: 30363469)
21. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
[TBL] [Abstract][Full Text] [Related]
22. Different loss of dopamine transporter according to subtype of multiple system atrophy.
Kim HW; Kim JS; Oh M; Oh JS; Lee SJ; Oh SJ; Chung SJ; Lee CS
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):517-25. PubMed ID: 26384682
[TBL] [Abstract][Full Text] [Related]
23. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.
Kim YJ; Ichise M; Ballinger JR; Vines D; Erami SS; Tatschida T; Lang AE
Mov Disord; 2002 Mar; 17(2):303-12. PubMed ID: 11921116
[TBL] [Abstract][Full Text] [Related]
24. Comparison of MRI and
Nishimori M; Murata Y; Iwasa H; Miyatake K; Tadokoro M; Kohsaki S; Nogami M; Hamada N; Ninomiya H; Osaki Y; Furuya H; Yamagami T
Biomed Rep; 2018 Jun; 8(6):523-528. PubMed ID: 29774142
[TBL] [Abstract][Full Text] [Related]
25. Serotonin transporter availability in early stage Parkinson's disease and multiple system atrophy.
Suwijn SR; Berendse HW; Verschuur CV; de Bie RM; Booij J
ISRN Neurol; 2014; 2014():345132. PubMed ID: 24693450
[TBL] [Abstract][Full Text] [Related]
26. Serotonin transporters in the midbrain of Parkinson's disease patients: a study with 123I-beta-CIT SPECT.
Kim SE; Choi JY; Choe YS; Choi Y; Lee WY
J Nucl Med; 2003 Jun; 44(6):870-6. PubMed ID: 12791812
[TBL] [Abstract][Full Text] [Related]
27. Dopamine transporter imaging with [
Jakobson Mo S; Axelsson J; Jonasson L; Larsson A; Ögren MJ; Ögren M; Varrone A; Eriksson L; Bäckström D; Af Bjerkén S; Linder J; Riklund K
EJNMMI Res; 2018 Nov; 8(1):100. PubMed ID: 30443684
[TBL] [Abstract][Full Text] [Related]
28. Dopamine transporter imaging for the diagnosis of multiple system atrophy cerebellar type.
Vergnet S; Hives F; Foubert-Samier A; Payoux P; Fernandez P; Meyer M; Dupouy J; Brefel-Courbon C; Ory-Magne F; Rascol O; Tison F; Pavy-Le Traon A; Meissner WG
Parkinsonism Relat Disord; 2019 Jun; 63():199-203. PubMed ID: 30745212
[TBL] [Abstract][Full Text] [Related]
29. Is
Kadodwala VH; Hadjivassiliou M; Currie S; Skipper N; Hoggard N
Cerebellum Ataxias; 2019; 6():7. PubMed ID: 31321064
[TBL] [Abstract][Full Text] [Related]
30. SPECT imaging of the dopamine transporter with [(123)I]-beta-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction.
Sakakibara R; Shinotoh H; Uchiyama T; Yoshiyama M; Hattori T; Yamanishi T
J Neurol Sci; 2001 Jun; 187(1-2):55-9. PubMed ID: 11440745
[TBL] [Abstract][Full Text] [Related]
31. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
[TBL] [Abstract][Full Text] [Related]
32. Importance of low-range CAG expansion and CAA interruption in SCA2 Parkinsonism.
Kim JM; Hong S; Kim GP; Choi YJ; Kim YK; Park SS; Kim SE; Jeon BS
Arch Neurol; 2007 Oct; 64(10):1510-8. PubMed ID: 17923635
[TBL] [Abstract][Full Text] [Related]
33. Validation of a standardized normalization template for statistical parametric mapping analysis of 123I-FP-CIT images.
Kas A; Payoux P; Habert MO; Malek Z; Cointepas Y; El Fakhri G; Chaumet-Riffaud P; Itti E; Remy P
J Nucl Med; 2007 Sep; 48(9):1459-67. PubMed ID: 17704252
[TBL] [Abstract][Full Text] [Related]
34. Functional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of 123I-beta-CIT SPECT data.
Ichise M; Kim YJ; Erami SS; Ballinger JR; Vines D; Tanaka F; Lang AE
J Nucl Med; 1999 Apr; 40(4):530-8. PubMed ID: 10210210
[TBL] [Abstract][Full Text] [Related]
35. Measurement of [123I]FP-CIT binding to the dopamine transporter (DAT) in healthy mouse striatum using dedicated small animal SPECT imaging: feasibility, optimization and validation.
Greco A; Zannetti A; Pappatà S; Albanese S; Coda AR; Ragucci M; Nardelli A; Brunetti A; Cuocolo A; Salvatore M
Q J Nucl Med Mol Imaging; 2018 Mar; 62(1):112-117. PubMed ID: 26329495
[TBL] [Abstract][Full Text] [Related]
36. Variability of FP-CIT PET Patterns Associated With Clinical Features of Multiple System Atrophy.
Lee R; Shin JH; Choi H; Kim HJ; Cheon GJ; Jeon B
Neurology; 2021 Mar; 96(12):e1663-e1671. PubMed ID: 33536274
[TBL] [Abstract][Full Text] [Related]
37. Evolution of Clinical Outcome Measures and Biomarkers in Sporadic Adult-Onset Degenerative Ataxia.
Oender D; Faber J; Wilke C; Schaprian T; Lakghomi A; Mengel D; Schöls L; Traschütz A; Fleszar Z; Dufke C; Vielhaber S; Machts J; Giordano I; Grobe-Einsler M; Klopstock T; Stendel C; Boesch S; Nachbauer W; Timmann-Braun D; Thieme AG; Kamm C; Dudesek A; Tallaksen C; Wedding I; Filla A; Schmid M; Synofzik M; Klockgether T
Mov Disord; 2023 Apr; 38(4):654-664. PubMed ID: 36695111
[TBL] [Abstract][Full Text] [Related]
38. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.
Brooks DJ; Salmon EP; Mathias CJ; Quinn N; Leenders KL; Bannister R; Marsden CD; Frackowiak RS
Brain; 1990 Oct; 113 ( Pt 5)():1539-52. PubMed ID: 2123119
[TBL] [Abstract][Full Text] [Related]
39. Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts.
Kraemmer J; Kovacs GG; Perju-Dumbrava L; Pirker S; Traub-Weidinger T; Pirker W
Mov Disord; 2014 Dec; 29(14):1767-73. PubMed ID: 25048738
[TBL] [Abstract][Full Text] [Related]
40. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
